Tivic Health Systems, INC S-1 registration statements

Valion Bio, Inc. has filed an S-1 registration statement detailing its offering of common stock and warrants, aiming to raise capital for R&D and general corporate purposes.

Tivic Health Systems, Inc. has filed an S-1 registration statement to allow for the resale of up to 956,222 shares of its common stock by Tumim Stone Capital, LLC.

Tivic Health Systems, Inc. filed an amended registration statement to allow a selling stockholder, Helena Global Investment Opportunities 1 Ltd., to resell up to 602,245 shares of common stock, stemming from a recent $8.4 million preferred stock and warrant purchase agreement.

Tivic Health Systems, Inc. has filed an S-1 registration statement to facilitate the resale of up to 8.4 million common shares by a selling stockholder, while simultaneously detailing a new financing agreement that could provide the company with up to $8.4 million in proceeds, despite an auditor's 'going concern' warning.

Tivic Health Systems is registering for the resale of up to 292,523 shares of its common stock by Mast Hill Fund, potentially generating up to $25 million for the company through a purchase agreement.

Tivic Health Systems aims to raise up to $7 million through a unit offering of common stock, warrants, and pre-funded warrants to support working capital and corporate purposes.

Health tech company Tivic Health Systems, Inc. is offering up to 6,481,481 shares of common stock and warrants to raise capital for working capital and general corporate purposes.

Tivic Health Systems is seeking to raise capital through a best efforts offering of common stock and warrants to fund working capital and general corporate purposes.